Saroja Pharma Industries Share Price Today | Stock Price & Saroja Pharma Industries Share Screener
Track the current Saroja Pharma Industries share price and stock price live with TickJournal's free stock screener. Check Saroja Pharma Industries yearly highs lows for the annual price range and momentum. Use the Saroja Pharma Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Saroja Pharma Industries opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Saroja Pharma Industries Share Price Chart
Track the current stock price of Saroja Pharma Industries with an interactive chart. Analyse SAROJA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Saroja Pharma Industries stock quote in one place.
Saroja Pharma Industries Company Profile - Fundamental Screener
Screen Saroja Pharma Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAROJA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE0PCL01011.
Company Details
Classification
Identifiers and Leadership
Saroja Pharma Industries Balance Sheet Screener
Screen SAROJA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹42, up from ₹40 in 2025.
Latest statistics put total assets at ₹42 and shareholder funds at ₹17, with a leverage ratio of 0.72.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
Assets |
||||||
| Total Assets | 42 | 40 | 27 | 21 | 16 | 8 |
| Current Assets | 19 | 27 | 18 | 16 | 15 | 8 |
| Fixed Assets | 2 | 3 | 3 | 2 | 0 | 0 |
Liabilities |
||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 7 | 1 | 3 | 3 | 2 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||
| Total Equity | 17 | 16 | 15 | 5 | 4 | 1 |
| Share Capital | 4 | 4 | 4 | 3 | 0 | 0 |
| Reserves & Surplus | 13 | 12 | 11 | 2 | 4 | 1 |
Saroja Pharma Industries Income Statement Screener - Profit & Revenue Analysis
Screen Saroja Pharma Industries income statement and profit fundamentals. Analyze SAROJA quarterly results. Saroja Pharma Industries reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹70 and net profit of ₹2.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||
| Revenue | 0 | 70 | 54 | 41 | 50 | 56 | 37 |
| Expenses | 0 | 66 | 51 | 38 | 48 | 54 | 35 |
Operating Costs and Margins | |||||||
| EBITDA | 0 | 4 | 3 | 3 | 3 | 2 | 1 |
| Operating Profit % | 0.00% | 5.00% | 5.00% | 6.00% | 5.00% | 4.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 2 | 1 | 1 | 1 | 1 | 0 |
Profit and Earnings | |||||||
| Profit Before Tax | 0 | 2 | 1 | 1 | 2 | 2 | 1 |
| Tax | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 2 | 1 | 1 | 1 | 1 | 1 |
| EPS | 0.00 | 4.02 | 2.57 | 2.49 | 3.61 | 3.96 | 2.69 |
Saroja Pharma Industries Cash Flow Screener - Liquidity Fundamentals
Screen SAROJA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹7.
Over the same period, investing activities used ₹12 and financing activities provided ₹4.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||
| Operating Activities | 7 | 1 | 1 | 2 | -4 | -1 |
| Investing Activities | -12 | -3 | -5 | -5 | 0 | 0 |
Financing and Net Cash | ||||||
| Financing Activities | 4 | 2 | 4 | 3 | 4 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
Saroja Pharma Industries Shareholding Pattern Screener
See Saroja Pharma Industries shareholding pattern with promoter, FII, and DII holdings. Check Saroja Pharma Industries promoter holding and ownership changes for SAROJA on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 73.02%, foreign institutions 0.00%, domestic institutions 0.00% and the public 22.60%, spread across 413 shareholders.
The shareholder count was 413 in 2026-Mar, compared with 422 in 2025-Mar.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Sept |
|---|---|---|---|---|---|---|
Promoter Holding | ||||||
| Promoter Holding | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% | 73.02% |
Institutional Investors | ||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.60% | 24.00% | 23.60% | 24.08% | 24.04% | 24.32% |
| Other Holding | 4.38% | 2.98% | 3.38% | 2.91% | 2.94% | 2.67% |
| Shareholder Count | 413 | 422 | 435 | 506 | 438 | 641 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Saroja Pharma Industries. Saroja Pharma Industries dividend yield can be compared with peers and other stocks in the market.
Saroja Pharma Industries Stock Index Membership - Nifty & Sensex
See which indices include Saroja Pharma Industries stock. Check SAROJA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Saroja Pharma Industries Market Events Screener - Corporate Actions
Get Saroja Pharma Industries corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Saroja Pharma Industries stock events that may affect SAROJA share price, along with derivatives, futures and options activity and sector gainers.
5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated May 30, 2026, with a record date of May 30, 2026.
It is followed by Quarterly Result Announcement dated November 13, 2025 and Quarterly Result Announcement dated May 28, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -1.52% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.40% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -6.89% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -7.61% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -7.10% |
Saroja Pharma Industries Competitors Screener - Peer Stocks Comparison
Screen SAROJA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 149,679 | 55.96 | 14,867 | 11.05% | 2,471 | 28.51 |
| SRF | 73,685 | 33.38 | 15,894 | 7.20% | 1,835 | 32.14 |
| Gujarat Fluorochemicals | 48,350 | 80.84 | 5,126 | 5.63% | 574 | 39.67 |
| Navin Fluorine International | 42,819 | 53.50 | 3,379 | 41.21% | 664 | 44.76 |
| Himadri Speciality Chemical | 34,422 | 41.86 | 4,832 | 3.60% | 755 | 45.55 |
| Aether Industries | 22,799 | 98.85 | 1,181 | 34.17% | 220 | 64.86 |
| Deepak Nitrite | 20,816 | 26.53 | 7,947 | -5.01% | 551 | 32.35 |
| Atul | 17,568 | 21.74 | 6,476 | 13.77% | 689 | 33.40 |
| Aarti Industries | 17,207 | 32.20 | 8,291 | 13.78% | 419 | 37.04 |
| Fine Organic Industries | 15,655 | 35.88 | 2,483 | 4.89% | 417 | 50.29 |
Saroja Pharma Industries Company Announcements - News & Reports Screener
Screen SAROJA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 0.90. Market capitalisation stands at ₹16.40 Cr. The company operates in the Chemicals sector, in the Specialty Chemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 7 income statement periods, 6 cash flow years and 6 shareholding periods. Information is provided for research and is not investment advice.